Literature DB >> 21621945

Australian community pharmacists' practice in complementary medicines: a structural equation modeling approach.

Tipaporn Kanjanarach1, Ines Krass, Robert G Cumming.   

Abstract

OBJECTIVE: This survey tested a model of factors influencing pharmacists' practice in relation to complementary medicines (CMs).
METHODS: Self-administered questionnaires were used to collect data from 212 community pharmacists in New South Wales. Structural equation modeling with AMOS version 6.0, was used to model two practices in relation to CMs: an evaluation of appropriateness of CM use and the decision to sell.
RESULTS: Pharmacists' perceptions of their responsibilities in ensuring the safe use of CMs predicted the comprehensiveness of an evaluation for appropriateness of CM use (P=0.002). When level of comprehensiveness of evaluation increased, pharmacists were less likely to sell CMs in situations where the use of the products was not considered appropriate (P=0.021). Pharmacists' confidence in their CM knowledge, attitudes towards CMs, concern about pharmacy income and pharmacists' characteristics did not significantly affect their practice.
CONCLUSION: Pharmacists' acceptance of their counseling responsibility with respect to CMs was the strongest predictor of both comprehensiveness of an evaluation and the decision to sell a CM. PRACTICE IMPLICATIONS: Pharmacists must be encouraged to recognise and accept their responsibility in ensuring the safe and effective use of CMs.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Year:  2011        PMID: 21621945     DOI: 10.1016/j.pec.2011.05.003

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  8 in total

1.  Consultations with complementary and alternative medicine practitioners amongst wider care options for back pain: a study of a nationally representative sample of 1,310 Australian women aged 60-65 years.

Authors:  Vijayendra Murthy; David Sibbritt; Jon Adams; Alex Broom; Emma Kirby; Kathryn M Refshauge
Journal:  Clin Rheumatol       Date:  2013-08-15       Impact factor: 2.980

2.  Consumers' experiences and values in conventional and alternative medicine paradigms: a problem detection study (PDS).

Authors:  Lynne Emmerton; Jasmina Fejzic; Susan E Tett
Journal:  BMC Complement Altern Med       Date:  2012-04-10       Impact factor: 3.659

3.  Factors affecting pharmacists' recommendation of complementary medicines - a qualitative pilot study of Australian pharmacists.

Authors:  Sarah E Culverhouse; Hans Wohlmuth
Journal:  BMC Complement Altern Med       Date:  2012-10-10       Impact factor: 3.659

4.  Knowledge, Attitude and Practice of Pharmacists regarding Dietary Supplements : A Community Pharmacy- based survey in Tehran.

Authors:  Gholamhossein Mehralian; Nazila Yousefi; Farshad Hashemian; Hanieh Maleksabet
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

5.  Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience.

Authors:  Carolina Oi Lam Ung; Joanna Harnett; Hao Hu
Journal:  BMC Complement Altern Med       Date:  2017-08-09       Impact factor: 3.659

6.  Community pharmacists' knowledge, attitude and practices towards the use of complementary and alternative medicines in Durban, South Africa.

Authors:  Yasmeen Thandar; Julia Botha; Anisa Mosam
Journal:  Health SA       Date:  2019-03-18

7.  The use of herbal medicines during breastfeeding: a population-based survey in Western Australia.

Authors:  Tin Fei Sim; Jillian Sherriff; H Laetitia Hattingh; Richard Parsons; Lisa B G Tee
Journal:  BMC Complement Altern Med       Date:  2013-11-13       Impact factor: 3.659

8.  Community pharmacists' knowledge, practices and beliefs about complementary and alternative medicine in Palestine: a cross-sectional study.

Authors:  Naser Y Shraim; Ramzi Shawahna; Muna A Sorady; Banan M Aiesh; Ghadeer Sh Alashqar; Raghad I Jitan; Waed M Abu Hanieh; Yasmeen B Hotari; Waleed M Sweileh; Sa'ed H Zyoud
Journal:  BMC Complement Altern Med       Date:  2017-08-29       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.